These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


425 related items for PubMed ID: 20837473

  • 1. Gossypol induces death receptor-5 through activation of the ROS-ERK-CHOP pathway and sensitizes colon cancer cells to TRAIL.
    Sung B, Ravindran J, Prasad S, Pandey MK, Aggarwal BB.
    J Biol Chem; 2010 Nov 12; 285(46):35418-27. PubMed ID: 20837473
    [Abstract] [Full Text] [Related]

  • 2. Azadirone, a limonoid tetranortriterpene, induces death receptors and sensitizes human cancer cells to tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) through a p53 protein-independent mechanism: evidence for the role of the ROS-ERK-CHOP-death receptor pathway.
    Gupta SC, Francis SK, Nair MS, Mo YY, Aggarwal BB.
    J Biol Chem; 2013 Nov 08; 288(45):32343-32356. PubMed ID: 24078627
    [Abstract] [Full Text] [Related]

  • 3. ROS and CHOP are critical for dibenzylideneacetone to sensitize tumor cells to TRAIL through induction of death receptors and downregulation of cell survival proteins.
    Prasad S, Yadav VR, Ravindran J, Aggarwal BB.
    Cancer Res; 2011 Jan 15; 71(2):538-49. PubMed ID: 21127198
    [Abstract] [Full Text] [Related]

  • 4. Capsazepine, a TRPV1 antagonist, sensitizes colorectal cancer cells to apoptosis by TRAIL through ROS-JNK-CHOP-mediated upregulation of death receptors.
    Sung B, Prasad S, Ravindran J, Yadav VR, Aggarwal BB.
    Free Radic Biol Med; 2012 Nov 15; 53(10):1977-87. PubMed ID: 22922338
    [Abstract] [Full Text] [Related]

  • 5. The herbal compound cryptotanshinone restores sensitivity in cancer cells that are resistant to the tumor necrosis factor-related apoptosis-inducing ligand.
    Tse AK, Chow KY, Cao HH, Cheng CY, Kwan HY, Yu H, Zhu GY, Wu YC, Fong WF, Yu ZL.
    J Biol Chem; 2013 Oct 11; 288(41):29923-33. PubMed ID: 23986445
    [Abstract] [Full Text] [Related]

  • 6. Quercetin enhances apoptotic effect of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in ovarian cancer cells through reactive oxygen species (ROS) mediated CCAAT enhancer-binding protein homologous protein (CHOP)-death receptor 5 pathway.
    Yi L, Zongyuan Y, Cheng G, Lingyun Z, Guilian Y, Wei G.
    Cancer Sci; 2014 May 11; 105(5):520-7. PubMed ID: 24612139
    [Abstract] [Full Text] [Related]

  • 7. Ilimaquinone induces death receptor expression and sensitizes human colon cancer cells to TRAIL-induced apoptosis through activation of ROS-ERK/p38 MAPK-CHOP signaling pathways.
    Do MT, Na M, Kim HG, Khanal T, Choi JH, Jin SW, Oh SH, Hwang IH, Chung YC, Kim HS, Jeong TC, Jeong HG.
    Food Chem Toxicol; 2014 Sep 11; 71():51-9. PubMed ID: 24930757
    [Abstract] [Full Text] [Related]

  • 8. Kaempferol Sensitizes Human Ovarian Cancer Cells-OVCAR-3 and SKOV-3 to Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL)-Induced Apoptosis via JNK/ERK-CHOP Pathway and Up-Regulation of Death Receptors 4 and 5.
    Zhao Y, Tian B, Wang Y, Ding H.
    Med Sci Monit; 2017 Oct 26; 23():5096-5105. PubMed ID: 29070784
    [Abstract] [Full Text] [Related]

  • 9. Ginsenoside compound K sensitizes human colon cancer cells to TRAIL-induced apoptosis via autophagy-dependent and -independent DR5 upregulation.
    Chen L, Meng Y, Sun Q, Zhang Z, Guo X, Sheng X, Tai G, Cheng H, Zhou Y.
    Cell Death Dis; 2016 Aug 11; 7(8):e2334. PubMed ID: 27512955
    [Abstract] [Full Text] [Related]

  • 10. Cardamonin sensitizes tumour cells to TRAIL through ROS- and CHOP-mediated up-regulation of death receptors and down-regulation of survival proteins.
    Yadav VR, Prasad S, Aggarwal BB.
    Br J Pharmacol; 2012 Feb 11; 165(3):741-53. PubMed ID: 21797841
    [Abstract] [Full Text] [Related]

  • 11. Tanshinone IIA Facilitates TRAIL Sensitization by Up-regulating DR5 through the ROS-JNK-CHOP Signaling Axis in Human Ovarian Carcinoma Cell Lines.
    Chang CC, Kuan CP, Lin JY, Lai JS, Ho TF.
    Chem Res Toxicol; 2015 Aug 17; 28(8):1574-83. PubMed ID: 26203587
    [Abstract] [Full Text] [Related]

  • 12. Gamma-tocotrienol promotes TRAIL-induced apoptosis through reactive oxygen species/extracellular signal-regulated kinase/p53-mediated upregulation of death receptors.
    Kannappan R, Ravindran J, Prasad S, Sung B, Yadav VR, Reuter S, Chaturvedi MM, Aggarwal BB.
    Mol Cancer Ther; 2010 Aug 17; 9(8):2196-207. PubMed ID: 20682650
    [Abstract] [Full Text] [Related]

  • 13. Medicarpin, a legume phytoalexin sensitizes myeloid leukemia cells to TRAIL-induced apoptosis through the induction of DR5 and activation of the ROS-JNK-CHOP pathway.
    Trivedi R, Maurya R, Mishra DP.
    Cell Death Dis; 2014 Oct 16; 5(10):e1465. PubMed ID: 25321472
    [Abstract] [Full Text] [Related]

  • 14. Casticin, a flavonoid, potentiates TRAIL-induced apoptosis through modulation of anti-apoptotic proteins and death receptor 5 in colon cancer cells.
    Tang SY, Zhong MZ, Yuan GJ, Hou SP, Yin LL, Jiang H, Yu ZΥ.
    Oncol Rep; 2013 Feb 16; 29(2):474-80. PubMed ID: 23135489
    [Abstract] [Full Text] [Related]

  • 15. Nimbolide sensitizes human colon cancer cells to TRAIL through reactive oxygen species- and ERK-dependent up-regulation of death receptors, p53, and Bax.
    Gupta SC, Reuter S, Phromnoi K, Park B, Hema PS, Nair M, Aggarwal BB.
    J Biol Chem; 2011 Jan 14; 286(2):1134-46. PubMed ID: 21078664
    [Abstract] [Full Text] [Related]

  • 16. 15-deoxy-Delta12,14-prostaglandin J2 up-regulates death receptor 5 gene expression in HCT116 cells: involvement of reactive oxygen species and C/EBP homologous transcription factor gene transcription.
    Su RY, Chi KH, Huang DY, Tai MH, Lin WW.
    Mol Cancer Ther; 2008 Oct 14; 7(10):3429-40. PubMed ID: 18852146
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Tunicamycin enhances human colon cancer cells to TRAIL-induced apoptosis by JNK-CHOP-mediated DR5 upregulation and the inhibition of the EGFR pathway.
    Guo X, Meng Y, Sheng X, Guan Y, Zhang F, Han Z, Kang Y, Tai G, Zhou Y, Cheng H.
    Anticancer Drugs; 2017 Jan 14; 28(1):66-74. PubMed ID: 27603596
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 22.